DISCLOSURE:
Shaw acted for the company in a corporate capacity within the past 12 months for which it received a fee. Shaw was an underwriter to the recent institutional placement.
No wonder they still have a BUY rating...
- Forums
- ASX - By Stock
- BLA
- Shaw and partners report
Shaw and partners report, page-8
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online